Bardy Diagnostics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
175
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.5M
Bardy Diagnostics General Information
Description
Developer of ambulatory cardiac monitoring devices designed to monitor and diagnose arrhythmia. The company's lightweight device is placed in the center of the chest, directly over the heart, for ECG and P-wave signal collection, enabling medical practitioners to track cardiac patients' heart rates remotely and improve decision-making.
Contact Information
Website
www.bardydx.com(Operating Subsidiary)
Corporate Office
- 220 120th Avenue North East
- Suite 100
- Bellevue, WA 98005
- United States
Corporate Office
- 220 120th Avenue North East
- Suite 100
- Bellevue, WA 98005
- United States
Bardy Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 08-May-2025 | $10.5M | Completed | Generating Revenue | ||
| 10. Merger/Acquisition | 02-Aug-2021 | Completed | Generating Revenue | |||
| 9. Merger/Acquisition | 15-Jan-2021 | Cancelled | Generating Revenue | |||
| 8. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 30-Mar-2020 | Cancelled | Generating Revenue | |||
| 6. Later Stage VC (Series B1) | 14-Feb-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 08-Aug-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 16-Apr-2019 | $35.5M | $70.9M | Completed | Generating Revenue | |
| 2. Grant | 26-Sep-2018 | $25K | $35.4M | Completed | Startup |
Bardy Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 30,254,053 | $0.001000 | $0.07 | $1.17 | $1.17 | 1x | $1.17 | 29.57% |
Bardy Diagnostics Comparisons
Industry
Financing
Details
Bardy Diagnostics Competitors (17)
One of Bardy Diagnostics’s 17 competitors is AliveCor, a Venture Capital-Backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AliveCor | Venture Capital-Backed | Mountain View, CA | ||||
| MedM | Accelerator/Incubator Backed | Sunnyvale, CA | ||||
| Huinno | Venture Capital-Backed | Seoul, South Korea | ||||
| CardioDiagnostics | Private Equity-Backed | Campbell, CA | ||||
| Medicomp | Formerly PE-Backed | Melbourne, FL |
Bardy Diagnostics Patents
Bardy Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4838546-A1 | Rose coil system for inductive charging | Pending | 05-May-2026 | ||
| US-20260352026-A1 | Rose coil system for inductive charging | Pending | 05-May-2025 | ||
| EP-4763084-A1 | Hydrogel containment solutions for thin-adhesive biomonitor | Pending | 23-Dec-2024 | ||
| US-20260174371-A1 | Hydrogel containment solutions for thin-adhesive biomonitor | Pending | 23-Dec-2024 | ||
| US-20260122057-A1 | Key management for medical devices | Pending | 25-Oct-2024 | H04L63/083 |
Bardy Diagnostics Signals
Bardy Diagnostics Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aperture Venture Partners | Venture Capital | Minority | ||
| Aphelion Capital | Venture Capital | Minority | ||
| Ascension Ventures | Corporate Venture Capital | Minority | ||
| HTA (Little Rock) | Accelerator/Incubator | Minority | ||
| Health Enterprise Partners | Growth/Expansion | Minority |
Bardy Diagnostics FAQs
-
When was Bardy Diagnostics founded?
Bardy Diagnostics was founded in 2013.
-
Where is Bardy Diagnostics headquartered?
Bardy Diagnostics is headquartered in Bellevue, WA.
-
What is the size of Bardy Diagnostics?
Bardy Diagnostics has 175 total employees.
-
What industry is Bardy Diagnostics in?
Bardy Diagnostics’s primary industry is Monitoring Equipment.
-
Is Bardy Diagnostics a private or public company?
Bardy Diagnostics is a Private company.
-
What is Bardy Diagnostics’s current revenue?
The current revenue for Bardy Diagnostics is .
-
How much funding has Bardy Diagnostics raised over time?
Bardy Diagnostics has raised $10.5M.
-
Who are Bardy Diagnostics’s investors?
Aperture Venture Partners, Aphelion Capital, Ascension Ventures, HTA (Little Rock), and Health Enterprise Partners are 5 of 14 investors who have invested in Bardy Diagnostics.
-
Who are Bardy Diagnostics’s competitors?
AliveCor, MedM, Huinno, CardioDiagnostics, and Medicomp are some of the 17 competitors of Bardy Diagnostics.
-
When was Bardy Diagnostics acquired?
Bardy Diagnostics was acquired on 08-May-2025.
-
Who acquired Bardy Diagnostics?
Bardy Diagnostics was acquired by Hill-Rom Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process